These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12937007)

  • 1. A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.
    Kurokawa H; Shibata N; Doi Y; Shibayama K; Kamachi K; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2981-3. PubMed ID: 12937007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E; Kühn A; Mack D; Laufs R
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.
    Mammeri H; Nazic H; Naas T; Poirel L; Léotard S; Nordmann P
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4050-3. PubMed ID: 15388478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
    Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
    Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB; Carias LL; Bonomo RA; Shlaes DM
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.
    Cartelle M; del Mar Tomas M; Molina F; Moure R; Villanueva R; Bou G
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2308-13. PubMed ID: 15155242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.
    Vakulenko S; Golemi D
    Antimicrob Agents Chemother; 2002 Mar; 46(3):646-53. PubMed ID: 11850243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.
    Poirel L; Mammeri H; Nordmann P
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4528-31. PubMed ID: 15561821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum beta-lactamase.
    Bou G; Martínez-Beltrán J; Cerveró G; Pérez-Díaz JC
    FEMS Microbiol Lett; 1999 May; 174(1):185-90. PubMed ID: 10234838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 11. CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli.
    Ma L; Ishii Y; Chang FY; Yamaguchi K; Ho M; Siu LK
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1985-8. PubMed ID: 12019121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae.
    Rasheed JK; Anderson GJ; Queenan AM; Biddle JW; Oliver A; Jacoby GA; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2000-3. PubMed ID: 12019125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
    Chanal-Claris C; Sirot D; Bret L; Chatron P; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Mar; 41(3):715-6. PubMed ID: 9056022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OHIO-1 beta-lactamase mutants: Asp179Gly mutation confers resistance to ceftazidime.
    Bonomo RA; Rudin SD; Shlaes DM
    FEMS Microbiol Lett; 1997 Jul; 152(2):275-8. PubMed ID: 9231421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten.
    Perilli M; Segatore B; Tavio M; Setacci D; Celenza G; De Santis F; Pellegrini C; Rossolini GM; Amicosante G
    J Chemother; 2007 Apr; 19(2):123-6. PubMed ID: 17434819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward.
    Hibbert-Rogers LC; Heritage J; Gascoyne-Binzi DM; Hawkey PM; Todd N; Lewis IJ; Bailey C
    J Antimicrob Chemother; 1995 Jul; 36(1):65-82. PubMed ID: 8537285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri.
    Yang Y; Bhachech N; Bradford PA; Jett BD; Sahm DF; Bush K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1671-6. PubMed ID: 9661002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
    Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.